With about 800,000 acute heart attacks occurring in the U.S. every year, and heart disease being the number one killer, you would think that a new clinical trial showing benefits from opening up all significantly blocked heart blood vessels in addition to the blocked artery responsible for the acute attack would merit big headlines.Read more here.
Think again. You would be wrong.
Not only were there no big headlines, there was no coverage at all.
Instead of headlines, all major U.S. mainstream media left a complete news blackout of the COMPLETE clinical trial. That's right, completely ZERO coverage. Just like it never happened.
"Complete" refers to complete revascularization of all the other significantly blocked coronary vessels in addition to the main culprit lesion responsible for the heart attack, which in this study was limited to ST-segment elevation myocardial infarction (STEMI). About 50% of STEMI patients have more than one blocked artery in addition to the culprit acute blockage.
Monday, September 23, 2019
Open them all!
Brant S. Mittler MD, JD, writes in MEDPAGE TODAY,
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment